Literature DB >> 11978154

Geriatric drug therapy and healthcare utilization in the United kingdom.

Anita Kennerfalk1, Ana Ruigómez, Mari-Ann Wallander, Lars Wilhelmsen, Saga Johansson.   

Abstract

OBJECTIVE: To describe the use of prescription drug therapy, especially polypharmacy, in an elderly general population; to relate that use to age, gender, and different types of healthcare utilization; and to investigate the influence of selection of different time windows on the result of the quantity as well as the categories of drugs used.
METHODS: Data on a sample of 5000 patients aged 65-90 years in 1996 were derived from the General Practice Research Database (GPRD). The population covered by GPRD is broadly representative of the UK population treated in general practice. Drug use was assessed using 2 time windows - current use of individual drugs on a random day (index date) and 1 month following the index date. Healthcare utilization was analyzed by use of information on visits to general practitioners (GPs), hospitalizations, and referrals to specialists.
RESULTS: Women used more drugs than men; however, the prevalence of polypharmacy, defined as concomitant use of > or =5 drugs, was similar in both genders. The most frequently used therapeutic groups were cardiovascular, central nervous, and gastrointestinal system drugs. Almost 80% of both women and men visited a GP at least once a year. Overall, women used more ambulatory care services and men were hospitalized more often. Use of random date compared with 1-month period resulted in a significant underestimation of the amount of drugs used for acute conditions and, consequently, the risk of polypharmacy.
CONCLUSIONS: The overall results confirm the findings in earlier studies suggesting that the GPRD might be a useful tool in further studies on prescription drug use among elderly persons. More information on the appropriateness of drug use is needed to prevent overuse as well as underuse of medications among the elderly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978154     DOI: 10.1345/aph.1A226

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  25 in total

Review 1.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

2.  Use of nonsteroidal anti-inflammatory drugs and coxibs in the elderly. Are we following the guidelines?

Authors:  Sergio Duran-Barragan; Anthony S Russell
Journal:  Clin Rheumatol       Date:  2008-07-12       Impact factor: 2.980

3.  Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.

Authors:  Kirsten K Viktil; Hege S Blix; Tron A Moger; Aasmund Reikvam
Journal:  Br J Clin Pharmacol       Date:  2006-08-30       Impact factor: 4.335

Review 4.  Antimuscarinic treatment in overactive bladder: special considerations in elderly patients.

Authors:  Adrian S Wagg
Journal:  Drugs Aging       Date:  2012-07-01       Impact factor: 3.923

5.  Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy.

Authors:  S Lane Slabaugh; Vittorio Maio; Megan Templin; Safiya Abouzaid
Journal:  Drugs Aging       Date:  2010-12-01       Impact factor: 3.923

6.  Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study.

Authors:  Johanna Jyrkkä; Leena Vartiainen; Sirpa Hartikainen; Raimo Sulkava; Hannes Enlund
Journal:  Eur J Clin Pharmacol       Date:  2006-01-12       Impact factor: 2.953

7.  Polypharmacy status as an indicator of mortality in an elderly population.

Authors:  Johanna Jyrkkä; Hannes Enlund; Maarit J Korhonen; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 8.  Statins and their interactions with other lipid-modifying medications: safety issues in the elderly.

Authors:  Clement K M Ho; Simon W Walker
Journal:  Ther Adv Drug Saf       Date:  2012-02

Review 9.  Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist.

Authors:  Victoria Rollason; Nicole Vogt
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Reasons for polypharmacy among psychiatric patients.

Authors:  Réka Viola; Katalin Csukonyi; Péter Doró; Zoltán Janka; Gyöngyvér Soós
Journal:  Pharm World Sci       Date:  2004-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.